药物难治性青少年肌阵挛癫痫患者的定量MRI指标与认知功能
这项前瞻性横断面两中心研究对药物难治性与药物反应性青少年肌阵挛癫痫(JME)患者及健康对照进行T1加权MRI和神经心理测量,发现药物难治性JME患者左侧颞叶表面积和左侧颞枕叶局部回旋指数增加,且执行功能 composite 评分降低,执行功能损害与楔前叶和内侧前额区域表面积增加相关。研究提示药物难治性JME具有发育表型,支持神经发育基础。
要点
- 药物难治性JME患者左侧颞叶表面积较药物反应性组增加(Cohen d = 0.82)。
- 药物难治性JME患者左侧颞叶和枕叶局部回旋指数增加(Cohen d = 0.60)。
- 药物难治性JME患者执行功能 composite 评分降低,与楔前叶和内侧前额区域表面积增加相关。
核心结论
- 药物难治性JME患者存在皮质表面积和折叠复杂度改变的发育表型,其程度与执行功能障碍相关,支持药物难治性和认知损害的神经发育基础。
研究设计与样本
- 前瞻性横断面两中心研究,纳入药物难治性JME 42例(平均年龄29±11岁,50%女性)、药物反应性JME 37例(平均年龄34±10岁,59%女性)和健康对照71例(平均年龄21±9岁,61%女性)。
主要发现
- 药物难治性JME组左侧颞叶表面积较药物反应性组增加(Cohen d = 0.82 [-0.52 to -1.12],pFWE < 0.05)。
- 药物难治性JME组左侧颞叶和枕叶局部回旋指数较药物反应性组增加(Cohen d = 0.60 [0.34-0.86],pFWE < 0.05),但与对照组相比未增加。
- 药物难治性JME组执行功能 composite 评分较对照组降低(-1.74 [-2.58 to -0.90],p < 0.001),较药物反应性组降低(-1.29 [-2.25 to -0.33],p < 0.01)。
- 药物难治性JME组执行功能损害与楔前叶和内侧前额区域表面积增加相关(r = -0.79,pFWE < 0.05)。
- 药物难治性与药物反应性JME组均较对照组出现离散的皮质变薄(Cohen d = -0.42 [-0.83 to -0.01],pFWE < 0.05;Cohen d = -0.57 [-1.03 to -0.11],pFWE < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Neuroimaging studies have so far identified structural changes in individuals with juvenile myoclonic epilepsy (JME) when compared with controls. However, the underlying mechanisms of drug-resistant JME remain unknown. In this study, we aimed at characterizing the structural underpinnings of drug-resistant JME using MRI-derived cortical morphologic markers. METHODS: In this prospective cross-sectional 2-center study, T1-weighted MRI and neuropsychological measures of verbal memory and executive function were obtained in individuals with drug-resistant and drug-responsive JME recruited from epilepsy outpatient clinics and healthy controls. We performed vertexwise measurements of cortical thickness, surface area, and local gyrification index (LGI). Vertexwise group comparisons were corrected for multiple comparisons at a familywise error (FWE) of 0.05. The neuropsychological profile of disease subgroups was analyzed through principal component analysis. RESULTS: We studied 42 individuals with drug-resistant JME (mean age 29 ± 11 years, 50% female), 37 with drug-responsive JME (mean age 34 ± 10, years, 59% female), and 71 healthy controls (mean age 21 ± 9 years, 61% female). Surface area was increased in participants with drug-resistant JME in the left temporal lobe (Cohen d = 0.82 [-0.52 to -1.12], pFWE < 0.05) when compared with the drug-responsive group. Although no cortical thickness changes were observed between disease subgroups, drug-resistant and drug-sensitive participants showed discrete cortical thinning against controls (Cohen d = -0.42 [-0.83 to -0.01], pFWE < 0.05; Cohen d = -0.57 [-1.03 to -0.11], pFWE < 0.05, respectively). LGI was increased in the left temporal and occipital lobes in drug-resistant participants (Cohen d = 0.60 [0.34-0.86], pFWE < 0.05) when contrasting against drug-sensitive participants, but not controls. The composite executive function score was reduced in drug-resistant individuals compared with controls and drug-sensitive individuals (-1.74 [-2.58 to -0.90], p < 0.001 and -1.29 [-2.25 to -0.33], p < 0.01, respectively). Significant correlations were observed between executive function impairment and increased surface area in the precuneus and medial prefrontal regions (r = -0.79, pFWE < 0.05) in participants with drug-resistant JME. DISCUSSION: We identified a developmental phenotype in individuals with drug-resistant JME characterized by changes in cortical surface area and folding complexity, the extent of which correlates with executive dysfunction. No association was observed between cortical thickness and disease severity. Our findings support a neurodevelopmental basis for drug resistance and cognitive impairment in JME.
引用
- Crespo Pimentel B, Kuchukhidze G, Xiao F, et al. Quantitative MRI Measures and Cognitive Function in People With Drug-Resistant Juvenile Myoclonic Epilepsy. Neurology. 2024. PMID: 39303180. doi:10.1212/WNL.0000000000209802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。